Clinical Trials Browser

Phase 1 × Myelodysplastic Syndromes × quisinostat × Clear all

NCT00676728 2012-09-14

A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome

Phase 1 Terminated

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes